Specify a stock or a cryptocurrency in the search bar to get a summary
Cuorips Inc.
4894Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan. Address: 507, Nihonbashi Life Science Building 2, Tokyo, Japan, 103-0023
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4894
Dividend Analytics 4894
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4894
Stock Valuation 4894
Financials 4894
Results | 2019 | Dynamics |